Skip to search
Skip to main content
Back to Search
Start Over
Corrigendum to “Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: Shedding new light on an old enzyme” [Blood Rev. 2023 Sep:61:101103] (Blood Reviews (2023) 61, (S0268960X23000644), (10.1016/j.blre.2023.101103))
Authors :
CDL Rode cel Unit Opleiding Aios Cancer Haematologie patientenzorg Poli Van Creveldkliniek Medisch Child Health Secretariaat Hematologie Circulatory Health CDL Cluster Speciële Diagnostiek van Dijk, Myrthe J. de Wilde, Jonathan R.A. Bartels, Marije Kuo, Kevin H.M. Glenthøj, Andreas Rab, Minke A.E. van Beers, Eduard J. van Wijk, Richard CDL Rode cel Unit Opleiding Aios Cancer Haematologie patientenzorg Poli Van Creveldkliniek Medisch Child Health Secretariaat Hematologie Circulatory Health CDL Cluster Speciële Diagnostiek van Dijk, Myrthe J. de Wilde, Jonathan R.A. Bartels, Marije Kuo, Kevin H.M. Glenthøj, Andreas Rab, Minke A.E. van Beers, Eduard J. van Wijk, Richard
Publication Year :
2024
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1453478901
Document Type :
Electronic Resource